ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

NMRA Neumora Therapeutics Inc

9.50
0.65 (7.34%)
22 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Neumora Therapeutics Inc NMRA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.65 7.34% 9.50 06:55:37
개장가 저가 고가 종가 전일 종가
8.83 8.67 9.535 9.50 8.85
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
20/06/202420:00GLOBENeumora Therapeutics Announces Initiation of Phase 1b Study..
15/06/202405:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/06/202405:01EDGAR2Form 8-K - Current report
14/05/202420:00GLOBENeumora Therapeutics Announces Initiation of Phase 2 Study..
08/05/202405:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202420:15EDGAR2Form 8-K - Current report
07/05/202420:00GLOBENeumora Therapeutics Reports First Quarter 2024 Financial..
06/05/202420:00GLOBENeumora Therapeutics to Participate in Upcoming Conferences..
15/04/202419:30GLOBENeumora Therapeutics Announces Clinical Hold of Phase 1..
13/03/202420:00GLOBENeumora Therapeutics to Participate at Stifel 2024 Virtual..
08/03/202406:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/03/202421:08EDGAR2Form 8-K - Current report
07/03/202421:00GLOBENeumora Therapeutics Reports Fourth Quarter and Full Year..
17/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/01/202421:00GLOBENeumora Therapeutics Appoints Kaya Pai Panandiker as Chief..
08/01/202422:32EDGAR2Form 8-K - Current report
02/01/202421:00GLOBENeumora Therapeutics to Present at 42nd Annual J.P. Morgan..
16/12/202307:06EDGAR2Form SC 13D/A - General statement of acquisition of..
12/12/202321:00GLOBENeumora Therapeutics Appoints Jason Duncan as Chief Legal..
29/11/202306:21EDGAR2Form 8-K - Current report
27/11/202321:00GLOBENeumora Therapeutics Announces NMRA-266 IND Clearance and..
02/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202305:01EDGAR2Form 8-K - Current report
01/11/202320:00GLOBENeumora Therapeutics Reports Third Quarter 2023 Financial..
30/10/202320:00GLOBENeumora Therapeutics to Participate in Upcoming Conferences..
10/10/202320:00GLOBENeumora Therapeutics Announces Appointment of Robert Lenz,..
20/09/202307:51KRMARKETNEWS인스타카트, 나스닥 데뷔로 주가는 12% 상승
15/09/202309:49GLOBENeumora Therapeutics Announces Pricing of Initial Public..

최근 히스토리

Delayed Upgrade Clock